GPCM
Granite Point Capital Management Portfolio holdings
AUM
$4.9M
This Quarter Return
+3.77%
1 Year Return
+15.68%
3 Year Return
+21.54%
5 Year Return
+22.27%
10 Year Return
–
AUM
$186M
AUM Growth
+$186M
(+9.7%)
Cap. Flow
-$8.76M
Cap. Flow
% of AUM
-4.72%
Top 10 Holdings %
Top 10 Hldgs %
43.82%
Holding
121
New
23
Increased
18
Reduced
31
Closed
27
Top Buys
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$5.28M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
$3.3M |
| 3 |
SAGE
Sage Therapeutics
SAGE
|
$2.97M |
| 4 |
Wabash National
WNC
|
$1.95M |
| 5 |
NetEase
NTES
|
$1.62M |
Top Sells
| 1 |
HIMX
Himax Technologies
HIMX
|
$4.01M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$3.31M |
| 3 |
MB
MINDBODY, Inc. Class A Common Stock
MB
|
$2.9M |
| 4 |
Advanced Micro Devices
AMD
|
$2.52M |
| 5 |
MYND
Mynd.ai
MYND
|
$2.28M |
Sector Composition
| 1 | Healthcare | 27.99% |
| 2 | Technology | 15.88% |
| 3 | Communication Services | 11.08% |
| 4 | Consumer Discretionary | 9.04% |
| 5 | Industrials | 6.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Wabash National
WNC
$451M
| $1.95M | 0.19% |
+90,000
| New | +$1.95M |
|
|
NVRO
27
DELISTED
NEVRO CORP.
NVRO
| $1.88M | 0.18% |
27,200
-900
| -3% | -$62.1K |
|
28
Amazon
AMZN
$2.41T
| $1.87M | 0.18% |
32,000
-4,000
| -11% | -$234K |
|
29
Bristol-Myers Squibb
BMY
$96.7B
| $1.84M | 0.18% |
30,000
| – | – |
|
30
Chart Industries
GTLS
$8.94B
| $1.79M | 0.18% |
38,200
-6,800
| -15% | -$319K |
|
|
FPRX
31
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $1.75M | 0.17% |
80,000
+30,000
| +60% | +$658K |
|
32
Bank of America
BAC
$371B
| $1.7M | 0.17% |
57,600
-6,200
| -10% | -$183K |
|
33
Kornit Digital
KRNT
$648M
| $1.58M | 0.15% |
98,000
+18,000
| +23% | +$291K |
|
34
New Oriental
EDU
$7.98B
| $1.58M | 0.15% |
16,800
+600
| +4% | +$56.4K |
|
35
TAL Education Group
TAL
$6.34B
| $1.52M | 0.15% |
51,100
-4,500
| -8% | -$134K |
|
36
AXT Inc
AXTI
$142M
| $1.5M | 0.15% |
172,000
+130,000
| +310% | +$1.13M |
|
|
CLLS
37
Cellectis
CLLS
$260M
| $1.46M | 0.14% |
+50,000
| New | +$1.46M |
|
38
Cigna
CI
$80.2B
| $1.42M | 0.14% |
7,000
| – | – |
|
39
CareDx
CDNA
$678M
| $1.4M | 0.14% |
+190,000
| New | +$1.4M |
|
|
CLVS
40
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.36M | 0.13% |
20,000
-10,700
| -35% | -$728K |
|
|
BFYT
41
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
| $1.26M | 0.12% |
50,500
+20,600
| +69% | +$514K |
|
|
ZYNE
42
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $1.25M | 0.12% |
100,000
-100,000
| -50% | -$1.25M |
|
43
Evolent Health
EVH
$1.11B
| $1.23M | 0.12% |
100,000
+50,000
| +100% | +$615K |
|
44
Dine Brands
DIN
$353M
| $1.19M | 0.12% |
23,400
-4,100
| -15% | -$208K |
|
45
Apple
AAPL
$3.54T
| $1.15M | 0.11% |
27,200
| – | – |
|
46
Prothena Corp
PRTA
$452M
| $1.13M | 0.11% |
+30,000
| New | +$1.13M |
|
47
Shake Shack
SHAK
$4.23B
| $1.12M | 0.11% |
26,000
-4,600
| -15% | -$199K |
|
|
ESIO
48
DELISTED
Electro Scientific Industries
ESIO
| $1.07M | 0.1% |
+50,000
| New | +$1.07M |
|
49
Wave Life Sciences
WVE
$1.27B
| $1.05M | 0.1% |
30,000
| – | – |
|
|
DERM
50
DELISTED
Dermira, Inc.
DERM
| $1.02M | 0.1% |
36,633
| – | – |
|